Search Count: 149
![]() |
Structure Of Human Hdac2 In Complex With Inhibitor N-(2-Amino-5-(Furan-2-Yl)Phenyl)-4-(1-((Phenylsulfonyl)Methyl)-1H-1,2,3-Triazol-4-Yl)Benzamid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-15 Classification: TRANSCRIPTION Ligands: ZN, CA, A1L4X, EDO, PEG, PGE, PG4, GOL |
![]() |
Structure Of Human Hdac2 In Complex With Inhibitor N-(2-Aminophenyl)-4-(1-((Phenylsulfonyl)Methyl)-1H-1,2,3-Triazol-4-Yl)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-15 Classification: TRANSCRIPTION Ligands: ZN, CA, A1L47, EDO, PEG, PGE, GOL, PG4 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-15 Classification: IMMUNE SYSTEM Ligands: NAG |
![]() |
Killer Immunoglobulin Receptor Kir2Dl2 In Complex With Kir2Dl2_Kir2Dl2/3 Agonist 61-Fab
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-15 Classification: IMMUNE SYSTEM Ligands: NAG |
![]() |
Killer Immunoglobulin Receptor Kir2Dl2 In Complex With Kir2Dl2_Kir2Dl2/3 Agonist 61-Scfv
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-15 Classification: IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-08 Classification: TRANSCRIPTION Ligands: ZN, CA, EDO, PEG, PGE, PG4, 1PE |
![]() |
Organism: Hepatitis b virus, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-06-04 Classification: VIRAL PROTEIN |
![]() |
Organism: Homo sapiens, Hepatitis b virus
Method: ELECTRON MICROSCOPY Release Date: 2025-06-04 Classification: VIRAL PROTEIN |
![]() |
Crystal Structure Of The Mutant Human Ror Gamma Ligand Binding Domain With Jte-151
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2024-11-27 Classification: NUCLEAR PROTEIN/INHIBITOR Ligands: YAL |
![]() |
Organism: Agrobacterium tumefaciens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-13 Classification: PROTEIN FIBRIL Ligands: XL0 |
![]() |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: ELECTRON MICROSCOPY Resolution:3.40 Å Release Date: 2023-12-27 Classification: VIRAL PROTEIN/PROTEIN BINDING Ligands: NAG, ZN, SO4 |
![]() |
Complex Structure Of Human Cytomegalovirus Protease And A Macrocyclic Peptide Ligand
Organism: Human betaherpesvirus 5, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:3.09 Å Release Date: 2023-11-08 Classification: HYDROLASE |
![]() |
Complex Structure Of Human Cytomegalovirus Protease And A Non-Covalent Small-Molecule Ligand
Organism: Human betaherpesvirus 5
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2023-11-08 Classification: HYDROLASE Ligands: T1F |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.90 Å Release Date: 2023-09-20 Classification: MEMBRANE PROTEIN Ligands: CD |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.15 Å Release Date: 2023-09-20 Classification: MEMBRANE PROTEIN Ligands: CD |
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2023-06-28 Classification: ANTITUMOR PROTEIN |
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2023-06-28 Classification: ANTITUMOR PROTEIN |
![]() |
Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) In Complex With Inhibitor Grl-142
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2023-03-22 Classification: VIRAL PROTEIN Ligands: 7OA, SO4 |
![]() |
Crystal Structure Of Human Adenosine A2A Receptor In Complex With An Insurmountable Inverse Agonist, Kw-6356.
Organism: Homo sapiens, Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2023-03-22 Classification: MEMBRANE PROTEIN/INHIBITOR Ligands: JQR, CLR, OLC, PE4, NA |
![]() |
Crystal Structure Of Human Adenosine A2A Receptor In Complex With Istradefylline.
Organism: Homo sapiens, Mus musculus
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2023-03-22 Classification: MEMBRANE PROTEIN/IMMUNE SYSTEM Ligands: JQ9, OLC, CL, K |




















